Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Calderon

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Plos One|May 22, 2013
A humanized mouse model of tuberculosisVeronica E Calderon, Gustavo Valbuena, Yenny Goez, et al.
Plastic and Reconstructive Surgery. Global Open|June 24, 2022
Emerging Trends in Botulinum Neurotoxin A Resistance: An International Multidisciplinary Review and ConsensusWilson W S Ho, Philipp Albrecht, Pacifico E Calderon, et al.
Scientific Reports|February 25, 2016
Pulmonary Tuberculosis in Humanized Mice Infected with HIV-1Rebecca J Nusbaum, Veronica E Calderon, Matthew B Huante, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 11, 2021
Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves RecoveryThuy-Vi V Nguyen, Rachel H Crumpacker, Kylie E Calderon, et al.
Carcinogenesis|May 1, 1996
An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from MexicoY Soini, S C Chia, W P Bennett, et al.
Scientific Reports|August 12, 2017
Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivationB Hernández-Ochoa, G Navarrete-Vázquez, C Nava-Zuazo, et al.
Nature Communications|July 27, 2024
Increased AID results in mutations at the CRLF2 locus implicated in Latin American ALL health disparitiesValeria Rangel, Jason N Sterrenberg, Aya Garawi, et al.
Annals of the Rheumatic Diseases|July 24, 2020
Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trialHermine I Brunner, Carlos Abud-Mendoza, Diego O Viola, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Plos One|May 22, 2013
A humanized mouse model of tuberculosisVeronica E Calderon, Gustavo Valbuena, Yenny Goez, et al.
Plastic and Reconstructive Surgery. Global Open|June 24, 2022
Emerging Trends in Botulinum Neurotoxin A Resistance: An International Multidisciplinary Review and ConsensusWilson W S Ho, Philipp Albrecht, Pacifico E Calderon, et al.
Scientific Reports|February 25, 2016
Pulmonary Tuberculosis in Humanized Mice Infected with HIV-1Rebecca J Nusbaum, Veronica E Calderon, Matthew B Huante, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 11, 2021
Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves RecoveryThuy-Vi V Nguyen, Rachel H Crumpacker, Kylie E Calderon, et al.
Carcinogenesis|May 1, 1996
An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from MexicoY Soini, S C Chia, W P Bennett, et al.
Scientific Reports|August 12, 2017
Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivationB Hernández-Ochoa, G Navarrete-Vázquez, C Nava-Zuazo, et al.
Nature Communications|July 27, 2024
Increased AID results in mutations at the CRLF2 locus implicated in Latin American ALL health disparitiesValeria Rangel, Jason N Sterrenberg, Aya Garawi, et al.
Annals of the Rheumatic Diseases|July 24, 2020
Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trialHermine I Brunner, Carlos Abud-Mendoza, Diego O Viola, et al.
Pageof 9